301 related articles for article (PubMed ID: 31222287)
21. Burden and risk factors for
Restrepo MI; Babu BL; Reyes LF; Chalmers JD; Soni NJ; Sibila O; Faverio P; Cilloniz C; Rodriguez-Cintron W; Aliberti S;
Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29976651
[No Abstract] [Full Text] [Related]
22. The incidence and etiology of community-acquired pneumonia in fever outpatients.
Bao Z; Yuan X; Wang L; Sun Y; Dong X
Exp Biol Med (Maywood); 2012 Nov; 237(11):1256-61. PubMed ID: 23239436
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary infections in immunosuppressed patients.
White DA; Santamauro JT
Curr Opin Pulm Med; 1995 May; 1(3):202-8. PubMed ID: 9363054
[TBL] [Abstract][Full Text] [Related]
24. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
25. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
[TBL] [Abstract][Full Text] [Related]
26. Community-acquired pneumonia related to intracellular pathogens.
Cillóniz C; Torres A; Niederman M; van der Eerden M; Chalmers J; Welte T; Blasi F
Intensive Care Med; 2016 Sep; 42(9):1374-86. PubMed ID: 27276986
[TBL] [Abstract][Full Text] [Related]
27. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
Ruiz M; Ewig S; Marcos MA; Martinez JA; Arancibia F; Mensa J; Torres A
Am J Respir Crit Care Med; 1999 Aug; 160(2):397-405. PubMed ID: 10430704
[TBL] [Abstract][Full Text] [Related]
28. The lung in the immunocompromised patient. Infectious complications Part 1.
Baughman RP
Respiration; 1999; 66(2):95-109. PubMed ID: 10202312
[TBL] [Abstract][Full Text] [Related]
29. [Radiographic imaging of bacterial pneumonia].
Ashizawa K; Uetani M
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():231-4. PubMed ID: 17455622
[No Abstract] [Full Text] [Related]
30. Acute community-acquired bacterial pneumonia in Human Immunodeficiency Virus (HIV) infected and non-HIV-infected adult patients in Cameroon: aetiology and outcome.
Koulla-Shiro S; Kuaban C; Belec L
Tuber Lung Dis; 1996 Feb; 77(1):47-51. PubMed ID: 8733414
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).
Chamilos G; Luna M; Lewis RE; Bodey GP; Chemaly R; Tarrand JJ; Safdar A; Raad II; Kontoyiannis DP
Haematologica; 2006 Jul; 91(7):986-9. PubMed ID: 16757415
[TBL] [Abstract][Full Text] [Related]
32. [Infection pathogen analysis of 2388 patients in an open hematology ward from 1993 to 2004].
Han B; Di HX; Zhou DB; Zhao YQ; Wang SJ; Xu Y; Chen JL; Duan Y; Jiao L; Duan MH; Zhang W; Zhu TN; Zou N; Shen T
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):664-8. PubMed ID: 16681921
[TBL] [Abstract][Full Text] [Related]
33. Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia.
Falcone M; Russo A; Giannella M; Cangemi R; Scarpellini MG; Bertazzoni G; Alarcón JM; Taliani G; Palange P; Farcomeni A; Vestri A; Bouza E; Violi F; Venditti M
PLoS One; 2015; 10(4):e0119528. PubMed ID: 25860142
[TBL] [Abstract][Full Text] [Related]
34. [Etiology of severe community-acquired pneumonia in immunocompromised patients].
Wu XJ; Gu SC; Cai Y; Zhai TS; Zhan QY
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Oct; 44(10):892-896. PubMed ID: 34565116
[No Abstract] [Full Text] [Related]
35. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
36. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Kollef MH; Chastre J; Fagon JY; François B; Niederman MS; Rello J; Torres A; Vincent JL; Wunderink RG; Go KW; Rehm C
Crit Care Med; 2014 Oct; 42(10):2178-87. PubMed ID: 25054674
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.
Koh SJ; Lee JH
Korean J Intern Med; 2015 Sep; 30(5):638-47. PubMed ID: 26354058
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical significance of common respiratory pathogens in the upper respiratory tract of children with community-acquired pneumonia in Zunyi, China.
Li X; Zhang W; Yao S; Zha H; Huang B; Liu D; Wu K
Pediatr Pulmonol; 2020 Sep; 55(9):2437-2443. PubMed ID: 32579285
[TBL] [Abstract][Full Text] [Related]
39. Community-acquired pneumonia with risk for drug-resistant pathogens.
Fleming V; Buck B; Nix N; Kumar P; Southwood R
South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
[TBL] [Abstract][Full Text] [Related]
40. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
Goa KL; Barradell LB
Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
